Novartis CEO Vas Narasimhan joins Anthropic board
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture
The company allocated €56 million to research and development for next-generation line solutions
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
Revvity is positioning its technologies as a connected engine for discovery
4th World Homoeopathy Summit at Palace of Westminster and University of Oxford spotlights integrative healthcare and global collaboration
Subscribe To Our Newsletter & Stay Updated